Literature DB >> 12898246

Histopathological parameters as predictors for the course of Crohn's disease.

Frauke Bataille1, Frank Klebl, Petra Rümmele, Rainer H Straub, Peter Wild, Jürgen Schölmerich, Ferdinand Hofstädter.   

Abstract

BACKGROUND: Recent classification systems discriminate penetrating Crohn's disease (CD) from stricturing and non-stricturing/non-penetrating CD. As yet, no easily detectable marker is known that can predict the course of CD. Individual, clinical course-specific new treatment schemes would be highly desirable for different potentially divergent pathophysiological pathways (e.g., fistula vs stenosis).
METHODS: Intestinal tissue biopsies from 63 CD patients with a disease follow-up of up to 7 years were studied retrospectively. In biopsy specimens, 34 histopathological features present prior to the onset of (a) strictures or (b) fistulas were evaluated and compared with biopsies from patients with non-stricturing/non-penetrating disease.
RESULTS: Five histomorphological parameters demonstrated significant associations to different disease courses when applying univariate analysis. In a multivariate logistic regression model (1) severe lymphocytic infiltration of the lamina propria, (2) presence of crypt atrophy, and (3) absence of lymphocytic infiltration of the epithelium are the best variables to predict an uncomplicated disease course (Nagelkerke R2=0.329; P=0.001). The combination of these parameters has a sensitivity of 67% and a specificity of 83% to predict non-stricturing/non-penetrating disease (positive predictive value=0.75).
CONCLUSION: Histopathological parameters may help to predict complications of CD prior to their onset. The results of this study have to be confirmed prospectively.

Entities:  

Mesh:

Year:  2003        PMID: 12898246     DOI: 10.1007/s00428-003-0863-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  22 in total

Review 1.  Prediction of treatment refractoriness in ulcerative colitis and Crohn's disease--do we have reliable markers?

Authors:  C M Gelbmann
Journal:  Inflamm Bowel Dis       Date:  2000-05       Impact factor: 5.325

2.  Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study.

Authors:  A G Røseth; M K Fagerhol; E Aadland; H Schjønsby
Journal:  Scand J Gastroenterol       Date:  1992-09       Impact factor: 2.423

3.  Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications.

Authors:  C A Seldenrijk; B C Morson; S G Meuwissen; N W Schipper; J Lindeman; C J Meijer
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

4.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

5.  Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.

Authors:  R Modigliani; J Y Mary; J F Simon; A Cortot; J C Soule; J P Gendre; E Rene
Journal:  Gastroenterology       Date:  1990-04       Impact factor: 22.682

6.  Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease.

Authors:  J A Tibble; G Sigthorsson; S Bridger; M K Fagerhol; I Bjarnason
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

7.  Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.

Authors:  M Tanaka; R H Riddell; H Saito; Y Soma; H Hidaka; H Kudo
Journal:  Scand J Gastroenterol       Date:  1999-01       Impact factor: 2.423

8.  CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease.

Authors:  Suzanne Lesage; Habib Zouali; Jean-Pierre Cézard; Jean-Frédéric Colombel; Jacques Belaiche; Sven Almer; Curt Tysk; Colm O'Morain; Miquel Gassull; Vibeke Binder; Yigael Finkel; Robert Modigliani; Corinne Gower-Rousseau; Jeanne Macry; Françoise Merlin; Mathias Chamaillard; Anne-Sophie Jannot; Gilles Thomas; Jean-Pierre Hugot
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

9.  Connective tissue changes in ileal Crohn's disease: relationship to disease phenotype and ulcer-associated cell lineage.

Authors:  N R Borley; N J Mortensen; M G Kettlewell; B D George; D P Jewell; B F Warren
Journal:  Dis Colon Rectum       Date:  2001-03       Impact factor: 4.585

10.  Differential lamina propria cell migration via basement membrane pores of inflammatory bowel disease mucosa.

Authors:  M E McAlindon; T Gray; A Galvin; H F Sewell; D K Podolsky; Y R Mahida
Journal:  Gastroenterology       Date:  1998-10       Impact factor: 22.682

View more
  7 in total

1.  Predictors of aggressive inflammatory bowel disease.

Authors:  Andres J Yarur; Sebastian G Strobel; Amar R Deshpande; Maria T Abreu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-10

2.  European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis.

Authors:  E F Stange; S P L Travis; S Vermeire; C Beglinger; L Kupcinkas; K Geboes; A Barakauskiene; V Villanacci; A Von Herbay; B F Warren; C Gasche; H Tilg; Stefan W Schreiber; J Schölmerich; W Reinisch
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

3.  Granuloma-positive Crohn's disease.

Authors:  Hugh J Freeman
Journal:  Can J Gastroenterol       Date:  2007-09       Impact factor: 3.522

4.  Histopathology Scoring Systems of Stenosis Associated With Small Bowel Crohn's Disease: A Systematic Review.

Authors:  Ilyssa O Gordon; Dominik Bettenworth; Arne Bokemeyer; Amitabh Srivastava; Christophe Rosty; Gert de Hertogh; Marie E Robert; Mark A Valasek; Ren Mao; Satya Kurada; Noam Harpaz; Paula Borralho; Reetesh K Pai; Rish K Pai; Robert Odze; Roger Feakins; Claire E Parker; Tran Nguyen; Vipul Jairath; Mark E Baker; David H Bruining; J G Fletcher; Brian G Feagan; Florian Rieder
Journal:  Gastroenterology       Date:  2019-08-30       Impact factor: 22.682

5.  Frequency and significance of granulomas in a cohort of incident cases of Crohn's disease.

Authors:  D Heresbach; J L Alexandre; B Branger; J F Bretagne; E Cruchant; A Dabadie; M Dartois-Hoguin; P M Girardot; H Jouanolle; J Kerneis; J C Le Verger; V Louvain; J Politis; M Richecoeur; M Robaszkiewicz; J A Seyrig
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

6.  Bowel wall thickening and hyperemia assessed by high-frequency ultrasound indicate histological inflammation in Crohn's ileitis.

Authors:  Ruediger S Goertz; Stefanie Hensel; Dane Wildner; Markus F Neurath; Deike Strobel
Journal:  Abdom Radiol (NY)       Date:  2020-12-24

7.  Histopathological Features in Colonic Biopsies at Diagnosis Predict Long-term Disease Course in Patients with Crohn's Disease.

Authors:  Ashkan Rezazadeh Ardabili; Danny Goudkade; Dion Wintjens; Mariëlle Romberg-Camps; Bjorn Winkens; Marie Pierik; Heike I Grabsch; Daisy Jonkers
Journal:  J Crohns Colitis       Date:  2021-11-08       Impact factor: 9.071

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.